Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plc | General Counsel | Ordinary Shares | 197K | $3.12M | $15.79 | Sep 30, 2024 | Direct |
Centessa Pharmaceuticals plc | General Counsel | Ordinary Shares | 5.5K | $86.8K | $15.79 | Sep 30, 2024 | By spouse |
Centessa Pharmaceuticals plc | General Counsel | Share Option (right to buy) | 170K | Feb 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CNTA | Centessa Pharmaceuticals plc | Sep 30, 2024 | 1 | -$119K | 4 | Oct 2, 2024 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Jun 30, 2024 | 1 | -$67.9K | 4 | Jul 2, 2024 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Mar 31, 2024 | 1 | -$85K | 4 | Apr 2, 2024 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Feb 1, 2024 | 3 | -$64.6K | 4 | Feb 2, 2024 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Dec 31, 2023 | 1 | -$59.9K | 4 | Jan 2, 2024 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Sep 30, 2023 | 1 | -$48.7K | 4 | Oct 3, 2023 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Jun 30, 2023 | 1 | -$41.9K | 4 | Jul 3, 2023 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Mar 31, 2023 | 1 | -$27.6K | 4 | Apr 4, 2023 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Feb 1, 2023 | 2 | $0 | 4 | Feb 3, 2023 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Dec 31, 2022 | 1 | -$12.4K | 4 | Jan 4, 2023 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Sep 30, 2022 | 1 | -$48.6K | 4 | Jan 13, 2023 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Sep 30, 2022 | 0 | $0 | 4/A | Nov 23, 2022 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | Jun 2, 2021 | 2 | $170K | 4 | Jun 4, 2021 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | May 27, 2021 | 3 | $0 | 4 | Jun 1, 2021 | General Counsel |
CNTA | Centessa Pharmaceuticals plc | May 27, 2021 | 0 | $0 | 3 | May 27, 2021 | General Counsel |